We Are Being Robbed by Pharma Cartel Profiteers

by | May 25, 2021 | Money and Politics

Photo by Cagkan Sayin, iStockphoto

We Are Being Robbed by Pharma Cartel Profiteers

by | May 25, 2021 | Money and Politics

Photo by Cagkan Sayin, iStockphoto
What is profiteering? It is “the act or activity of making an unreasonable profit on the sale of essential goods especially during times of emergency.” For anyone who needs an essential medication for their health, an emergency would be not having that drug.

I went to the pharmacy the other day to pick up a prescription. Unfortunately, having had asthma most of my life, I need to take a daily puff of a drug that helps with it. It is made by GlaxoSmithKlein, a British Pharma outfit that also does big business in the United States. Judging from my personal experience, a massive amount of that business is pure, unadulterated profiteering.

So what is profiteering? It is “the act or activity of making an unreasonable profit on the sale of essential goods especially during times of emergency.” For anyone who needs an essential medication for their health, an emergency would be not having that drug.

What is an excess or unreasonable profit? At first this might seem to be a pretty subjective and hard to define datum. In the case of GlaxoSmithKlein (GSK), I can assure you it is pretty easy to demonstrate.

Back to my prescription. The co-pay for my medicine—an inhaled medication called Breo Elipta—was $97 for a 30-day supply. It is delivered in a specially designed system that measures out one puff per day. The cost without my very good insurance coverage would have been well over $400. So how do we know there is an excessive and unreasonable profit being generated by GSK?

Well it so happens that I was in South Africa in 2019 and needed to get a refill. In Commonwealth countries, the same formulation—with a slight dosage variation—is sold under the name Relvar Ellipta. Also made by GSK, it has the exact same specialized delivery system, one dose per day. Since my insurance was not going to work in South Africa I had to pay cash. The price? The Rand equivalent of $38.

There is no way GSK, which has a massive presence in Johannesburg, would be selling this product at a loss.

One can conclude the obvious that American customers are simply being ripped off. This is not the only medication GSK runs this scam with. Another example is another one of their asthma products, Advair. Again a specialized delivery system. The last time I purchased this one, the 30-day supply was almost $400 without insurance. I bought this over the counter at an open-air pharmacy in Tijuana, genuine product from GSK, same delivery system, but with a different name sticker. The price was $72—for a 60-day supply.

Calling the major pharma companies cartels is deliberate. Here’s the actual definition of cartel, “an association of manufacturers or suppliers with the purpose of maintaining prices at a high level and restricting competition.” There is not much daylight between the pharma companies and the drug/gun thugs of Medellín or Sinaloa.

These “legal” drug cartels have taken advantage of the United States market for far too long and show no signs of changing course. They have built vast mechanisms to keep the flow of excess profits pouring into their coffers.

A great example is the company GoodRX. This is a company that actually makes no sense. It advertises major discounts for major drugs. But those discounts are actually a small percentage and could be chalked up as promotion costs. The real purpose of the company is to normalize price gouging. Making a person “feel good” with a 10 percent price reduction off a drug that is already 10 times the price of another country is just a scam.

We are simply being robbed. If this makes you feel outraged, good. We need some national outrage on this subject. Our pockets are being picked on a massive scale.

Let’s take a quick look at how big this rip-off really is. Let’s start with a relatively known number. There are approximately 25 million asthma sufferers in the United States. If just 10 percent of these people use Breo Elipta to help control their symptoms, based on the differential between the US cash price and South Africa’s, that comes to approximately $100 million per month in excess profits, or $1.2 billion annually. And this is based on an assumption of a 10-percent market share. That is just a look at one drug for asthma. Meanwhile, the price of insulin has been inflated to many hundreds of dollars per month. You get the idea.

When you hear about the vast “unworkability” of Medicare for All, or how it is some sort of a communist plot, etc., etc., realize that those arguments are there to protect the profit river of these cartels. There is a reason that out of all the industrialized countries in the world, we are the only one that can’t “figure out” universal healthcare. This is one of the key reasons.

0 Comments

Submit a Comment

Your email address will not be published.

Related Articles

May 17 2022

Documents Reveal How Drug Companies Targeted Doctors to Increase Opioid Prescriptions

A document trove shows firsthand how drug companies targeted doctors and used information purchased from data brokers to rank them and gain insight on how many of their...
May 16 2022

The Testing Lab That Missed 96% of Covid Cases

State and local officials across Nevada signed agreements with Northshore Clinical Labs, a COVID testing laboratory run by men with local political connections. There...
May 14 2022

The Facts Surrounding the U.S. Baby Formula Shortage

As Republican fear mongers like Elise Stefanik whip out conspiracy accusations and blame about the baby formula shortage, the real facts from a pediatrician are more...
May 13 2022

Rick Scott — Florida Man Gaslights Himself

Rick Scott has published an 11-point proposal to raise taxes on the poorest of Americans and set the stage to destroy Medicare and Social Security. But he now claims it...
May 12 2022

Watergate — A New History of the Abuse of White House Power

As the 50th anniversary of the Watergate break-in approaches, a recent book charts the transformation of the Nixon administration’s bungled burglary into a wake-up call...
May 11 2022

Baby Formula Has Become the Latest Supply Chain-Monopoly Battleground

Six states are seeing baby formula shortages of more than 50% and stores are limiting purchases to three or four per customer, with prices surging to $33 per can.
May 07 2022

Healthcare Profiteering: Medical Bills Force a Family to Get Care in Mexico

The Fierro family was trapped in a situation of being “functionally uninsured.” They have insurance, but their healthcare plan is expensive and they don’t have the...
May 06 2022

Fossil Fuel Democrats Join GOP Senators Trying to Prevent Biden From Declaring Climate Emergency

Though the Senate resolution is non-binding, it clearly shows the fear the fossil fuel industry has of impending actions to reverse the damage they are causing to our...
May 02 2022

Private Utility Companies Also Got Into the Pandemic Profiteering Act

A new report details how private utility companies shut off electricity to U.S. households more than 3.5 million times since the start of the Covid-19 pandemic, even...
May 01 2022

Pumped Up Inflation: Big Oil Profits Double and Quadruple Amid Ukraine Crisis Excuses

One of the major factors of the current “inflation” is Big Oil intentionally profiteering off the war in Ukraine. Pump prices remain sky high even though no...
Subscribe for Updates!

Subscribe for Updates!

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!

Pin It on Pinterest

Share This